714 reports of this reaction
4.0% of all BOSUTINIB reports
#3 most reported adverse reaction
FATIGUE is the #3 most commonly reported adverse reaction for BOSUTINIB, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 714 FDA adverse event reports linking BOSUTINIB to FATIGUE. This represents approximately 4.0% of all 17,905 adverse event reports for this drug.
Patients taking BOSUTINIB who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among BOSUTINIB users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for BOSUTINIB:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 714 FDA reports for BOSUTINIB. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 4.0% of all adverse event reports for BOSUTINIB, making it one of the most commonly reported side effect.
If you experience fatigue while taking BOSUTINIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.